TY  - RPRT
TI  - The metronomic combination of paclitaxel with cholinergic agonists inhibits triple negative breast tumor progression. Participation of M2 receptor subtype
AU  - Espanol, A.
AU  - Salem, A.
AU  - Di Bari, M.
AU  - Cristofaro, I.
AU  - Sanchez, Y.
AU  - Tata, A.
AU  - Sales, M. E.
PY  - 2019
DO  - 10.1101/858969
UR  - https://www.biorxiv.org/content/10.1101/858969v1
ID  - 10.1101/858969
ER  -